Terms: = Prostate cancer AND PR, PGR, progesterone receptor AND Treatment
321 results:
1. Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH.
Guerrios-Rivera L; Janes JL; De Hoedt AM; Klaassen Z; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Fowke JH; Freedland SJ
Cancer Med; 2024 Feb; 13(4):e7012. PubMed ID: 38457188
[TBL] [Abstract] [Full Text] [Related]
2. treatments Targeting the Androgen receptor and Its Splice Variants in Breast cancer.
Tien AH; Sadar MD
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339092
[TBL] [Abstract] [Full Text] [Related]
3. First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Piha-Paul SA; Xu B; Dumbrava EE; Fu S; Karp DD; Meric-Bernstam F; Hong DS; Rodon JA; Tsimberidou AM; Raghav K; Ajani JA; Conley AP; Mott F; Fan Y; Fan J; Peng P; Wang H; Ni S; Sun C; Qiang X; Levin WJ; Ngo B; Ru QC; Wu F; Javle MM
Oncologist; 2024 Apr; 29(4):e514-e525. PubMed ID: 38297981
[TBL] [Abstract] [Full Text] [Related]
4. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
5. [Erectile disfunction after treatment for prostate cancer].
Nicolai MPJ
Ned Tijdschr Geneeskd; 2023 Oct; 167():. PubMed ID: 37823885
[TBL] [Abstract] [Full Text] [Related]
6. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
7. Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin).
Patwardhan CA; Kommalapati VK; Llbiyi T; Singh D; Alfa E; Horuzsko A; Korkaya H; Panda S; Reilly CA; Popik V; Chadli A
Sci Rep; 2023 Aug; 13(1):13790. PubMed ID: 37612326
[TBL] [Abstract] [Full Text] [Related]
8. Early biochemical and radiographic response after one cycle of [
Cytawa W; Hendel R; Tomasik B; Weinzierl FX; Bley T; Jassem J; Schirbel A; Buck AK; Bundschuh RA; Hartrampf PE; Werner RA; Lapa C
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3765-3776. PubMed ID: 37474735
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic efficacy and safety results of 177Lu-PSMA therapy in metastatic castration-resistant prostate cancer patients: first experience of a developing South Asian Country.
Parveen A; Fatima A; Fatima I; Khan IU; Shahid A
Nucl Med Commun; 2023 Oct; 44(10):876-887. PubMed ID: 37440195
[TBL] [Abstract] [Full Text] [Related]
10. Relative Burden of cancer and Noncancer Mortality Among Long-Term Survivors of Breast, prostate, and Colorectal cancer in the US.
Kc M; Fan J; Hyslop T; Hassan S; Cecchini M; Wang SY; Silber A; Leapman MS; Leeds I; Wheeler SB; Spees LP; Gross CP; Lustberg M; Greenup RA; Justice AC; Oeffinger KC; Dinan MA
JAMA Netw Open; 2023 Jul; 6(7):e2323115. PubMed ID: 37436746
[TBL] [Abstract] [Full Text] [Related]
11. cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review.
Anbarasu S; Anbarasu A
Med Oncol; 2023 May; 40(6):171. PubMed ID: 37162589
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of Rectal cancer in Which Total Pelvic Organ Excision Could Be Avoided by TNT Therapy and Robotic Surgery].
Hayashi N; Kagawa Y; Inoue A; Nishizawa Y; Komatsu H; Miyazaki Y; Tomokuni A; Takahashi A; Hotta N; Fukui A; Murayama H; Goto M; Motoori M; Iwase K; Fujitani K
Gan To Kagaku Ryoho; 2023 Feb; 50(2):200-202. PubMed ID: 36807171
[TBL] [Abstract] [Full Text] [Related]
13. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
Standing D; Dandawate P; Anant S
Front Endocrinol (Lausanne); 2022; 13():1112987. PubMed ID: 36714582
[TBL] [Abstract] [Full Text] [Related]
14. Extended therapy with [
Mader N; Nguyen Ngoc C; Kirkgöze B; Baumgarten J; Groener D; Klimek K; Happel C; Tselis N; Chun FKH; Grünwald F; Sabet A
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1811-1821. PubMed ID: 36702927
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Role of
Lunger L; Chantadisai M; Karimzadeh A; Rauscher I; D'Alessandria C; Feuerecker B; Langbein T; Tauber R; Schiele S; Weber W; Eiber M
J Nucl Med; 2023 Jun; 64(6):896-901. PubMed ID: 36581373
[TBL] [Abstract] [Full Text] [Related]
16. Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males.
Mahbub AA; Aslam A; Elzubier ME; El-Boshy M; Abdelghany AH; Ahmad J; Idris S; Almaimani R; Alsaegh A; El-Readi MZ; Baghdadi MA; Refaat B
Front Endocrinol (Lausanne); 2022; 13():941834. PubMed ID: 36263327
[TBL] [Abstract] [Full Text] [Related]
17. Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.
Alamiri J; Britton CJ; Ahmed ME; Andrews JR; Higa JL; Dundar A; Karnes RJ; Kwon E; Lowe VJ; Kendi AT; Bold MS; Pagliaro LC
Prostate; 2022 Dec; 82(16):1483-1490. PubMed ID: 36089822
[TBL] [Abstract] [Full Text] [Related]
18. High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation.
Hjälm-Eriksson M; Ullén A; Nilsson S; Johansson H; Nilsson J; Castellanos E; Brandberg Y
Acta Oncol; 2022 Oct; 61(10):1179-1185. PubMed ID: 36062835
[TBL] [Abstract] [Full Text] [Related]
19. Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other cancer Entities.
Fendler WP; Pabst KM; Kessler L; Fragoso Costa P; Ferdinandus J; Weber M; Lippert M; Lueckerath K; Umutlu L; Kostbade K; Mavroeidi IA; Schuler M; Ahrens M; Rischpler C; Bauer S; Herrmann K; Siveke JT; Hamacher R
Clin Cancer Res; 2022 Oct; 28(19):4346-4353. PubMed ID: 35833949
[TBL] [Abstract] [Full Text] [Related]
20. Novel Framework for treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant prostate cancer (RECIP 1.0): An International Multicenter Study.
Gafita A; Rauscher I; Weber M; Hadaschik B; Wang H; Armstrong WR; Tauber R; Grogan TR; Czernin J; Rettig MB; Herrmann K; Calais J; Weber WA; Benz MR; Fendler WP; Eiber M
J Nucl Med; 2022 Nov; 63(11):1651-1658. PubMed ID: 35422442
[TBL] [Abstract] [Full Text] [Related]
[Next]
